Cargando…

Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias

ABSTRACT: Dominant spinocerebellar ataxias (SCAs) constitute a large group of phenotypically and genetically heterogeneous disorders that mainly present with dysfunction of the cerebellum as their main hallmark. Although animal and cell models have been highly instrumental for our current insight in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hommersom, Marina P., Buijsen, Ronald A. M., van Roon-Mom, Willeke M. C., van de Warrenburg, Bart P. C., van Bokhoven, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930896/ https://www.ncbi.nlm.nih.gov/pubmed/34031815 http://dx.doi.org/10.1007/s12015-021-10184-0

Ejemplares similares

Therapeutic Strategies for Spinocerebellar Ataxia Type 1
por: Kerkhof, Laurie M. C., et al.
Publicado: (2023)

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)

The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
por: van Prooije, Teije, et al.
Publicado: (2023)

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
por: Toonen, Lodewijk J.A., et al.
Publicado: (2017)

Correction to: The potential value of disease-modifying therapy in patients with spinocerebellar ataxia type 1: an early health economic modeling study
por: van Prooije, Teije, et al.
Publicado: (2023)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia
por: Mohamed Ibrahim, Norlinah, et al.
Publicado: (2020)

Discordance Between Patient-Reported Outcomes and Physician-Rated Motor Symptom Severity in Early-to-Middle-Stage Spinocerebellar Ataxia Type 3
por: Maas, Roderick P. P. W. M., et al.
Publicado: (2021)

Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells
por: Burman, Richard J., et al.
Publicado: (2021)

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
por: Toonen, Lodewijk J. A., et al.
Publicado: (2018)

Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia Type 3: a Randomized, Double-Blind, Sham-Controlled Trial
por: Maas, Roderick P. P. W. M., et al.
Publicado: (2022)

Reply: A homozygous GDAP2 loss-of-function variant in a patient with adult-onset cerebellar ataxia; and Novel GDAP2 pathogenic variants cause autosomal recessive spinocerebellar ataxia-27 (SCAR27) in a Chinese family
por: Eidhof, Ilse, et al.
Publicado: (2020)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

Nonmotor symptoms in spinocerebellar ataxias (SCAs)
por: Moro, Adriana, et al.
Publicado: (2019)

Stage-dependent biomarker changes in spinocerebellar ataxia type 3
por: Faber, Jennifer, et al.
Publicado: (2023)

Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans
por: van de Leemput, Joyce, et al.
Publicado: (2007)

Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3 (SCA3-tDCS): rationale and protocol of a randomized, double-blind, sham-controlled study
por: Maas, Roderick P. P. W. M., et al.
Publicado: (2019)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Correction to: Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3 (SCA3-tDCS): rationale and protocol of a randomized, double-blind, sham-controlled study
por: Maas, Roderick P. P. W. M., et al.
Publicado: (2021)

Amyloid beta accumulations and enhanced neuronal differentiation in cerebral organoids of Dutch-type cerebral amyloid angiopathy patients
por: Daoutsali, Elena, et al.
Publicado: (2023)

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
por: Wilke, Carlo, et al.
Publicado: (2020)

Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells
por: Ou, Zhanhui, et al.
Publicado: (2016)

Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3
por: Faber, Jennifer, et al.
Publicado: (2021)

Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid Angiopathy
por: Daoutsali, Elena, et al.
Publicado: (2021)

Diagnosis of Spinocerebellar Ataxia in the West Indies
por: Yearwood, Ashley K., et al.
Publicado: (2018)

Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Neuroradiological Findings in the Spinocerebellar Ataxias
por: Meira, Alex Tiburtino, et al.
Publicado: (2019)

Generalized myokymia, or neuromyotonia, or both in dogs with or without spinocerebellar ataxia
por: Vanhaesebrouck, An, et al.
Publicado: (2023)

The cerebral metabolic topography of spinocerebellar ataxia type 3
por: Meles, Sanne K., et al.
Publicado: (2018)

Therapeutic Misestimation in Patients with Degenerative Ataxia: Lessons from a Randomized Controlled Trial
por: Maas, Roderick P.P.W.M., et al.
Publicado: (2022)

Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias
por: Kishimoto, Yoshiyuki, et al.
Publicado: (2022)

On Spinocerebellar Ataxia 21 as a Mimicker of Cerebral Palsy
por: van der Put, Johanna, et al.
Publicado: (2022)

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6
por: Tezenas du Montcel, Sophie, et al.
Publicado: (2014)

Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2
por: Dabla, Surekha, et al.
Publicado: (2022)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

Protein-protein interaction networks in the spinocerebellar ataxias
por: Rubinsztein, David C
Publicado: (2006)

Integrative network and brain expression analysis reveals mechanistic modules in ataxia
por: Eidhof, Ilse, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_leghtelns9oagpt63kd6t610qt